Real-world CMV Outcomes Among Kidney Transplant Recipients in Brazil

Launched by HOSPITAL DO RIM E HIPERTENSÃO · Feb 8, 2024

Keywords

ClinConnect Summary

Data will be collected from medical records and will include transplant recipient characteristics, transplant-related information, CMV status, clinical outcomes, treatment patterns, healthcare resource utilization and captured on an electronic Intake Form.

Study-specific Case Report (eCRF) The sponsor will create a Statistical Analysis Plan (SAP) before collection begins of data. The eCRF system will comply with research regulations

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Received a single kidney transplant after January 1, 2018
• • Age over 18 years at time of kidney transplant.
• • It was under preemptive strategy.
• • Diagnosed with CMV infection/disease within the first 12 months after kidney transplant.
• • Follow-up information is available in medical records for at least 12 months after confirmation of CMV infection, or even loss of the allograft, death of the recipient or loss of follow-up of the receiver, when/if applicable.
• Exclusion Criteria:
• • Diagnosed as a carrier of the human immunodeficiency virus (HIV+), hepatitis B virus and/or hepatitis C before kidney transplantation.
• • Participation in any interventional study during the period between kidney transplantation and a period of 12 months after CMV diagnosis.